DEXAMETHASONE AND ETOPOSIDE INDUCE APOPTOSIS IN RAT THYMOCYTES FROM DIFFERENT PHASES OF THE CELL-CYCLE

被引:34
作者
FEARNHEAD, HO [1 ]
CHWALINSKI, M [1 ]
SNOWDEN, RT [1 ]
ORMEROD, MG [1 ]
COHEN, GM [1 ]
机构
[1] UNIV LEICESTER, MRC TOXICOL UNIT, LEICESTER LE1 9HN, ENGLAND
关键词
QUIESCENT; PROLIFERATING AND PREAPOPTOTIC CELLS; BROMODEOXYURIDINE; PERCOLL;
D O I
10.1016/0006-2952(94)90142-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dexamethasone and etoposide both induce apoptosis in immature rat thymocytes. We investigated the dependence of apoptosis on the phase of the cell cycle after incubation with these drugs. Cell cycle progression was followed by a combination of pulse labelling with 5-bromo-2'-deoxyuridine (BrdU), labelling fixed cells with an anti-BrdU antibody and flow cytometry. Dexamethasone had little effect on the cell cycle progression of proliferating thymocytes, while etoposide caused cell cycle arrest. Normal and apoptotic thymocytes were separated by centrifugation on discontinuous Percoll gradients into four fractions (F1-F4). It was found that both dexamethasone and etoposide induced apoptosis in cells in G0/G1 and G2/M of the cell cycle, whereas only etoposide induced apoptosis of cells in S phase. These results demonstrated that dexamethasone induced apoptosis in quiescent cells while only etoposide could induce apoptosis in cells from the proliferative compartment. Following treatment of thymocytes with etoposide, some of the proliferating thymocytes (F1) were converted to cells with intermediate size and density (F3). We have recently identified these cells as a population of preapoptotic thymocytes, at an early stage of apoptosis. These cells then further progressed to fully apoptotic cells (F4). These data support the hypothesis that normal thymocytes (F1) became apoptotic (F4) via an intermediate population (F3).
引用
收藏
页码:1073 / 1079
页数:7
相关论文
共 29 条
[1]  
BRUNO S, 1992, ONCOL RES, V4, P29
[2]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[3]  
COHEN GM, 1993, J IMMUNOL, V151, P566
[4]  
COHEN JJ, 1991, ADV IMMUNOL, V50, P55
[5]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[6]   FEATURES OF APOPTOTIC CELLS MEASURED BY FLOW-CYTOMETRY [J].
DARZYNKIEWICZ, Z ;
BRUNO, S ;
DELBINO, G ;
GORCZYCA, W ;
HOTZ, MA ;
LASSOTA, P ;
TRAGANOS, F .
CYTOMETRY, 1992, 13 (08) :795-808
[7]  
DELBINO G, 1991, CANCER RES, V51, P1165
[8]  
DELBINO G, 1992, CELL PROLIFERAT, V25, P537
[9]  
EARNSHAW WC, 1990, EUKARYOTIC NUCLEUS M, V2, P639
[10]   DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASES-I AND TOPOISOMERASES-II DURING THE EUKARYOTIC CELL-CYCLE [J].
HECK, MMS ;
HITTELMAN, WN ;
EARNSHAW, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (04) :1086-1090